Cellular Immune Augmentation in Colon and Rectal Cancer
NCT00257322
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Colon Cancer
Rectal Cancer
Interventions
DRUG:
GM-CSF
Sponsor
University of California, Irvine